109 related articles for article (PubMed ID: 36804121)
1. A novel L-phenylalanine dipeptide inhibits prostate cancer cell proliferation by targeting TNFSF9.
Zhang D; Liu B; Hu L; Yu J; Cheng S; Ahmad M; Xu BX; Luo H
Biomed Pharmacother; 2023 Apr; 160():114360. PubMed ID: 36804121
[TBL] [Abstract][Full Text] [Related]
2. A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.
Li L; Yang M; Yu J; Cheng S; Ahmad M; Wu C; Wan X; Xu B; Ben-David Y; Luo H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142828
[TBL] [Abstract][Full Text] [Related]
3. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
[TBL] [Abstract][Full Text] [Related]
4. TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages.
Wu J; Wang Y; Yang Y; Liu F; Chen J; Jiang Z; Jiang Z
Aging (Albany NY); 2021 Sep; 13(17):21571-21586. PubMed ID: 34517345
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
Nadiminty N; Tummala R; Lou W; Zhu Y; Shi XB; Zou JX; Chen H; Zhang J; Chen X; Luo J; deVere White RW; Kung HJ; Evans CP; Gao AC
PLoS One; 2012; 7(3):e32832. PubMed ID: 22479342
[TBL] [Abstract][Full Text] [Related]
6. Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer.
Costa BP; Schein V; Zhao R; Santos AS; Kliemann LM; Nunes FB; Cardoso JCR; Félix RC; Canário AVM; Brum IS; Branchini G
Mol Cell Endocrinol; 2020 Feb; 502():110659. PubMed ID: 31816356
[TBL] [Abstract][Full Text] [Related]
7. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
8. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
[TBL] [Abstract][Full Text] [Related]
9. Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.
Kurniawati I; Liu MC; Hsieh CL; Do AD; Sung SY
Front Biosci (Landmark Ed); 2022 Sep; 27(9):256. PubMed ID: 36224011
[TBL] [Abstract][Full Text] [Related]
10. β
Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C
Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788
[TBL] [Abstract][Full Text] [Related]
11. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
[TBL] [Abstract][Full Text] [Related]
12. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
Chiyomaru T; Yamamura S; Fukuhara S; Yoshino H; Kinoshita T; Majid S; Saini S; Chang I; Tanaka Y; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(8):e70372. PubMed ID: 23936419
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
14. Investigating the Multi-Target Pharmacological Mechanism of
Song Y; Wang H; Pan Y; Liu T
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
[No Abstract] [Full Text] [Related]
15. TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.
Shen YL; Gan Y; Gao HF; Fan YC; Wang Q; Yuan H; Song YF; Wang JD; Tu H
J Dig Dis; 2017 Jul; 18(7):395-403. PubMed ID: 28547807
[TBL] [Abstract][Full Text] [Related]
16. Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
Liu YQ; Hu XY; Lu T; Cheng YN; Young CY; Yuan HQ; Lou HX
PLoS One; 2012; 7(5):e38000. PubMed ID: 22666431
[TBL] [Abstract][Full Text] [Related]
17. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
18. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin B regulates lung cancer cell proliferation and apoptosis
Liu JH; Li C; Cao L; Zhang CH; Zhang ZH
Pharm Biol; 2022 Dec; 60(1):154-162. PubMed ID: 34967707
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
